| |
NASA has plenty to worry about these days, including trying to shoehorn a $40 billion space station into its budget without gutting its science programs. But the fact that 30 percent of its work force is ...
Maybe It Should Be General Healy Retirements Not Seen As Hurting NASA Not Now Dear, I Have A Political Headache The High Cost Of Outreach Mixed News on NSF Funding Trends President Bush came to NIH last month to swear in the agency's new director, Bernadine Healy. While the occasion was entirely ceremonial--she took office April 9--Healy used it to make a characteristically bold statement about NIH's mission. Referring to its mandate to improve the nation's health, Healy declared that
| |
NASA has plenty to worry about these days, including trying to shoehorn a $40 billion space station into its budget without gutting its science programs. But the fact that 30 percent of its work force is ...


When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.


In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.

In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.


Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.


Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST

Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.

Collaboration will bring next generation orchestration and modular automation to scientists worldwide

The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.